A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...

This off-label treatment for an autoimmune disease in a child had never been attempted anywhere in the world, as far as ... with the idea of trying CAR-T cell therapy. "Up to now, this type ...

VHIO and IMIM are evaluating a new CAR T-cell therapy in a phase 1 trial for tumors driven by HER2 overexpression. The CARxALL clinical trial, launched in 2023 in Barcelona, is the world’s only ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge ...

During a live event, Konstantinos Sdrimas, MD, asked participants what community oncologists should consider when referring ...

CAR T-cell therapy carried a risk of second primary malignancy (SPM) that was no worse than that of other standard-of-care (SOC) cancer therapies, according to a systematic literature review and ...

Their study, published recently in Nature Medicine, (1) included a comprehensive analysis of NRM after CAR T cell therapy in patients with lymphoma and multiple myeloma across multiple clinical trials ...

CAR-T Therapy Won't Raise Odds for a Second Cancer ... Rejeski and colleagues reviewed data from 18 clinical trials and seven "real-world" studies involving more than 5,500 patients with lymphoma ...

The girl, who is now 16 years old, was the first child with SLE to receive the immune therapy ... world, as far as we knew,” says senior physician Krickau. This treatment involves removing some immune ...